Sam Bhayani, M.D.

Assistant Professor, Surgery
Division of Urologic Surgery


Ongoing Research

Funding Agency: GTx, Inc
Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men with High Grade Prostatic Intraepithelial Neoplasia (PIN)


Funding Agency: Duramed
Title: A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind, Dose-Ranging Clinical Trial To Study the Efficacy and Safety of 5, 15, or 25mg/day CyPat™ (Cyproterone Acetate) for the Treatment of Hot Flashes Following Surgical or Medical Castration of Prostate Cancer Patients

Dr. Bhayani's CV.